Hayleys Lifesciences (Pvt) Ltd, a supplier of cutting-edge analytical, surgical, and radiology equipment and consumables has introduced the state-of-the-art Dornier Medilas H140 to improve access to urological stone treatment.
This technology addresses a pressing societal need in a nation with a high prevalence of kidney patients and a scarcity of advanced treatment facilities.
The Medilas H140, developed by Dornier MedTech, is a cutting-edge Holmium: YAG Laser that combines precision and safety in treating kidney stone patients, setting a new standard for urological stone treatments in Sri Lanka. One of the highest-powered Holmium: YAG Lasers in the market today, the machine offers safer and faster stone fragmentation by combining the prowess of a laser and morcellator in a single device, a company spokesman said.
The Dornier Medilas H140 is available at the Teaching Hospital in Anuradhapura and the Teaching Hospital in Kalutara.
Hayleys Lifesciences Deputy Managing Director, Athula Wijayananda said, “Our mission is to advance healthcare excellence in our nation. The Medilas H140 significantly enhances patients’ access to urological stone treatments in Sri Lanka, addressing a pressing societal need. The technology provides patients with precise, safe, and minimally invasive alternatives to the conventional shockwave therapy.”
In the past, shockwave therapy was administered externally, and its effectiveness depended on the power of the shockwave applied. The Medilas H140 laser treatment reduces the possibility and risk of post-operative complications.
Laser treatment, particularly the PCNL (Percutaneous Nephro Lithotripsy) approach, represents a significant leap forward in urological stone treatments. This minimally invasive procedure involves a 2 to 4-mm incision, allowing for a nephroscope to access and observe the stone. A laser, guided by advanced technology is employed to remove the stone efficiently and safely.
